• About Amgen
  • Science
  • Corporate Giving
  • Site Map
  • Search
  • Privacy & Terms
  • Contact Us
Amgen
  • Patients
  • Medical Professionals
  • Partners
  • Investors
  • Careers
  • Media
  • print
  • mail
  • Home
  • Medical Professionals
  • Products

  • Overview
  • Products
  • Update to U.S. Prescribing Information for Aranesp® and EPOGEN®
  • Counterfeit Drug Statement
  • Information on Aranesp® Phase 3 Study in Cancer Patients
  • PRCA Update
  • Disease / Condition Info
  • Clinical Trials
  • Resources
  • R&D Vision
  • Reimbursement Connection®
  • Medical Information
  • Pharmacy Affairs
Products
  • By Name
  • By Disease



Aranesp® (darbepoetin alfa)

View Product Details
 

Enbrel® (etanercept)

View Product Details
 

EPOGEN® (Epoetin alfa)

View Product Details
 

Kepivance® (palifermin)

View Product Details
 

Kineret® (anakinra)

View Product Details
 

Neulasta® (pegfilgrastim)

View Product Details
 

NEUPOGEN® (Filgrastim)

View Product Details
 

Sensipar® (cinacalcet)

View Product Details
 

Vectibix® (panitumumab)

View Product Details
 

Total of 9 Products
footer